company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,4316308.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1177708.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1349898.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,204642.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,7048556.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,365801.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,335880.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,29921.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1903561.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,2231509.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1791662.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,284625.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6211357.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,,totalassets,Total Assets,=,debit,usd,13289834.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,501278.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,472279.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,227696.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,958451.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,2159704.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,560878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,560878.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,2720582.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,121721004.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-111095229.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,10625775.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,10625775.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-56523.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,10569252.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2011.0,Q3,,2011-06-30,2011-08-08 16:08:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,13289834.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,6773126.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,71828.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2027620.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,301334.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,9173908.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,7650430.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,723190.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6927240.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1730220.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,2321258.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2749593.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,160125.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,6961196.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,,totalassets,Total Assets,=,debit,usd,23062344.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,209555.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,714057.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2386796.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,101042.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,637691.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1010883.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5060024.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,702695.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1444370.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,106345.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2253410.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7313434.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,1.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,136423898.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-116357257.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-3897500.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,16169141.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,16169142.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-420232.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,15748910.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q1,,2011-12-31,2012-02-09 16:07:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,23062344.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3595112.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,78680.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,2357900.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2329266.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,456603.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,8817561.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,7817653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,1072439.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6745214.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1665959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,6264.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,2675478.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,170500.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4518201.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,,totalassets,Total Assets,=,debit,usd,20080976.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,211602.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,801104.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2383651.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,69792.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1159624.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1749748.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6375521.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,748104.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1390665.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2138769.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8514290.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,136593289.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-121692489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-2665000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,12235800.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,12235800.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-669114.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,11566686.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q2,,2012-03-31,2012-05-08 16:05:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,20080976.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2282641.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,108965.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,2401602.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,677447.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,432379.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,5903034.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,6786959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,1421170.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5365789.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,187000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentassets,noncurrentnotereceivables,Noncurrent Note & Lease Receivables,+,debit,usd,34891.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4685063.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,312250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,5219204.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,,totalassets,Total Assets,=,debit,usd,16488027.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,213196.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,994372.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1022734.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,71875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1051079.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2462160.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5815416.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,793513.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1336764.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,93731.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2224008.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8039424.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,140049267.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-129683999.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-1000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,9365268.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,9365268.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-916665.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,8448603.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2012.0,Q3,,2012-06-30,2012-08-13 16:11:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,16488027.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,2931032.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,56008.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentassets,notereceivable,Note & Lease Receivable,+,debit,usd,2491450.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,124571.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,460922.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,6063983.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,6367948.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,1941265.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4426683.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4710454.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,30011.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4740465.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,,totalassets,Total Assets,=,debit,usd,15231131.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1151748.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,809524.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,842639.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,109375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1067763.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2096929.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6077978.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,50000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1227743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,270931.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1548674.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,7626652.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,150086619.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-139611839.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-1500000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,8974780.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,8974780.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1370301.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,7604479.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q1,,2012-12-31,2013-02-13 16:10:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,15231131.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,3313483.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,426398.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,3739881.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,6329009.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,2315915.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4013094.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,4636339.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,30011.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4666350.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,,totalassets,Total Assets,=,debit,usd,12419325.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1098287.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,871707.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,823517.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,65625.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1222573.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3082317.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7164026.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,50000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1172616.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,272179.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1494795.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8658821.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,151682662.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-146369775.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5312887.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5312887.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1552383.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3760504.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q2,,2013-03-31,2013-05-09 16:08:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,12419325.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29025930.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,4058003.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,267560.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1059503.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,34410996.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,6489197.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,2695886.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3793311.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3254177.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,30011.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3284188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,,totalassets,Total Assets,=,debit,usd,41488495.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1145339.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1061944.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,706092.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,71875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,811046.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2881570.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6677866.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,50000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1117074.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,337587.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1504661.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8182527.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,10.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,187405744.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-152448785.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,34956959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,34956969.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1651001.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,33305968.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2013.0,Q3,,2013-06-30,2013-08-07 16:29:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,41488495.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59713424.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,15912757.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,95488.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,689954.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,76411623.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,netppe,grossppe,"Plant, Property & Equipment, gross",+,debit,usd,6461837.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,netppe,accumulateddepreciation,Accumulated Depreciation,-,credit,usd,3275690.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3186147.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3226850.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,9867857.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,13094707.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,,totalassets,Total Assets,=,debit,usd,92692477.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1271345.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,589348.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,684520.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,109375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,678035.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,5685785.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9018408.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,1006398.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1757384.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2763782.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11782190.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,51.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,259500814.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-176769281.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,82731533.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,82731584.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1821297.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,80910287.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q1,,2013-12-31,2014-02-04 16:33:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,92692477.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,142847860.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,17798475.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,643023.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,633807.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,161923165.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3290270.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3213186.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,34214773.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,37427959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,,totalassets,Total Assets,=,debit,usd,202641394.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,1262234.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2511572.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,913856.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,65625.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,732131.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,4997122.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10482540.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,865777.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1755520.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2621297.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13103837.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,21.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,382110813.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-190711800.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,191399013.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,191399034.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-1861477.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,189537557.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q2,,2014-03-31,2014-05-06 15:56:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,202641394.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,138349733.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,23834408.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,700063.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,538742.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,163422946.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,3674131.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,26284862.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,3199523.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,29525799.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,,totalassets,Total Assets,=,debit,usd,196622876.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4281829.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2158133.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1068667.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,71875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,611092.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,58500.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8250096.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,812169.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1752822.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2564991.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,10815087.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,21.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,388703583.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-202340717.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,186362866.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,186362887.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555098.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,185807789.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2014.0,Q3,,2014-06-30,2014-08-12 16:00:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,196622876.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,103991231.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,23532402.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,127000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4451124.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,62841.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,132164598.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4124441.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,17806499.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,999809.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,7041414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,25847722.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,,totalassets,Total Assets,=,debit,usd,162136761.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,213991.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5994951.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1148092.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,109375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2175484.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1855772.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11497665.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,705173.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4224252.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4929425.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,16427090.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,18.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,393611282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-247346441.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,146264841.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,146264859.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,145709671.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q1,,2014-12-31,2015-02-09 16:09:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,162136761.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,96447301.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,19561172.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3811096.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,327384.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,120146953.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4127366.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,12361068.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,25701657.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41414.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,38104139.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,,totalassets,Total Assets,=,debit,usd,162378458.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,215762.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4936282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5041174.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,65625.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1272001.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1679517.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13210361.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,650014.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4321729.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4971743.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18182104.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,16.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,420848344.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-276032853.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-63965.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,144751526.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,144751542.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,144196354.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q2,,2015-03-31,2015-05-11 16:06:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,162378458.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87252813.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,23280640.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3499324.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,654924.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,114687701.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4108667.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1085282.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,25262886.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,45789.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,26393957.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,,totalassets,Total Assets,=,debit,usd,145190325.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,216653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4862263.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1726449.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,71875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,884373.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1770875.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9532488.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,595516.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4317927.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4913443.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,14445931.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,16.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,423334418.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-291968905.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-65947.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,131299566.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,131299582.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,130744394.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2015.0,Q3,,2015-06-30,2015-08-04 16:02:20+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,145190325.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,62165088.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,14431498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3783344.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1903884.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,82283814.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4666411.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,24385125.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,45789.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,24430914.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,,totalassets,Total Assets,=,debit,usd,111381139.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,218447.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5288922.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3920312.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,109375.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1419423.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1371535.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12328014.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,485842.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6198891.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6684733.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,19012747.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,16.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,428990626.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-335976455.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-90607.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,92923564.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,92923580.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,92368392.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q1,,2015-12-31,2016-02-09 16:16:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,111381139.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,50300847.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,11160442.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3772643.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,909561.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,66143493.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4381628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,23960017.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,122333.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,24082350.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,,totalassets,Total Assets,=,debit,usd,94607471.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,219349.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7542498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3834269.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,65625.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1395004.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1001600.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14058345.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,430665.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6192224.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6622889.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,20681234.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,16.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,431213811.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-356792315.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,59913.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,74481409.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,74481425.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,73926237.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q2,,2016-03-31,2016-05-10 16:11:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,94607471.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43616543.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1030556.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3446863.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1507470.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,49601432.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,12274821.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,23534910.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,122333.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,23657243.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,,totalassets,Total Assets,=,debit,usd,85533496.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,361088.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5945370.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6263349.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,26042.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1129460.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1114959.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14840268.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2583330.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,378862.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2243406.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,6062464.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11268062.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,26108330.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,16.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,436224107.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-376213057.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-30712.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,59980338.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,59980354.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,59425166.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2016.0,Q3,,2016-06-30,2016-08-09 16:51:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85533496.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,102105569.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,60000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,569415.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,3495369.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,106230353.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16165659.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,21739761.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,122333.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21862094.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,,totalassets,Total Assets,=,debit,usd,144258106.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,197713.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3698297.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4762105.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,26024761.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,2150014.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,165202.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,36998092.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2482775.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,7368818.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10051593.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,47049685.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,508469919.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-410521151.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-185159.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,97763609.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,97763609.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,97208421.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q1,,2016-12-31,2017-02-06 16:16:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,144258106.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61718971.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,24910492.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,580825.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,731834.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1747801.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,89689923.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15714948.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,21314653.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,152119.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21466772.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,,totalassets,Total Assets,=,debit,usd,126871643.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,201247.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2597889.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2184844.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,21609771.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,765292.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,192585.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,27551628.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2431118.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3352408.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5983526.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33535154.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,510486082.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-416563710.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-30695.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,93891677.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,93891677.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,93336489.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q2,,2017-03-31,2017-05-03 16:13:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,126871643.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38383135.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,36754754.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,937313.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,931042.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,896150.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77902394.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16134991.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,20889546.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,154618.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,21044164.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,,totalassets,Total Assets,=,debit,usd,115081549.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,204844.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3233421.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,1993674.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13723586.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1034569.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,129520.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20319614.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2378538.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2641113.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5219651.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25539265.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,512199310.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-422083452.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-18386.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,90097472.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,90097472.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,89542284.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2017.0,Q3,,2017-06-30,2017-08-03 16:11:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,115081549.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11531345.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,39169376.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,149931.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,651239.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1604986.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,53106877.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14932366.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,20039332.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,141918.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,20181250.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,,totalassets,Total Assets,=,debit,usd,88220493.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,212233.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5707047.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3478512.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2315581.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1936024.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,66852.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,13716249.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2270542.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1834392.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4304934.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,18021183.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,516745010.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-446014216.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,23704.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,70754498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,70754498.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,70199310.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q1,,2017-12-31,2018-02-09 16:11:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,88220493.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,69805117.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,21736820.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,16288.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,744246.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,357989.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,92660460.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14582313.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19614224.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,141918.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,19756142.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,,totalassets,Total Assets,=,debit,usd,126998915.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,216027.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1810431.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4127208.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2005580.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,918226.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,46407.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,9123879.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2215091.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1744863.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4159954.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,13283833.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,575143532.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-460898527.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25265.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,114270270.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,114270270.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,113715082.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q2,,2018-03-31,2018-05-08 16:11:49+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,126998915.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,27995386.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,32484708.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14975.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1095977.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,279049.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,61870095.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14029239.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,17672658.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,19189117.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,141918.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,37003693.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,,totalassets,Total Assets,=,debit,usd,112903027.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,219889.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2165731.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2163533.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,1383780.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1147780.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,46407.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,7127120.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2158649.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,1657899.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,200000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,4016548.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11143668.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,578822430.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-476504545.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-3338.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,102314547.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,102314547.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,101759359.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2018.0,Q3,,2018-06-30,2018-08-07 16:12:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,112903027.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,189772981.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,53980307.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3168578.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1550437.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,478310.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,248950613.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13920667.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,59595287.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,18338903.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,141918.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,78076108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,,totalassets,Total Assets,=,debit,usd,340947388.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3936590.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3907515.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,125137797.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1629871.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,134611773.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,34835584.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,34835584.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,169447357.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,647327526.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-475228563.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43744.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,172055219.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,172055219.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,171500031.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q1,,2018-12-31,2019-02-07 16:50:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,340947388.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,161639208.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,56560674.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13422340.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1757928.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1590195.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,234970345.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13378321.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,67536054.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,17913795.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,141918.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,85591767.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,,totalassets,Total Assets,=,debit,usd,333940433.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4062189.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5718774.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,91063753.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,967674.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,101812390.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,31487807.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,31487807.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,133300197.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,652598911.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-451331581.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-71906.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,201195424.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,201195424.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,200640236.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q2,,2019-03-31,2019-05-08 16:12:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,333940433.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,188331747.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,1000000.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,48567215.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2044111.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3103476.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,1492175.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,244538724.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17074613.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,57555499.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,17488688.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,170921.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,75215108.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,,totalassets,Total Assets,=,debit,usd,336828445.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4630244.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5173146.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,75855820.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,1427855.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,87087065.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24071340.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,24071340.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,111158405.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,657324178.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-430995872.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-103078.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,226225228.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,226225228.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalequityandnoncontrollinginterests,noncontrollinginterests,Noncontrolling Interest,+,credit,usd,-555188.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,225670040.0
Arrowhead Pharmaceuticals Inc,ARWR,549300O3CSB8T7OZ3D66,0000879407,2019.0,Q3,,2019-06-30,2019-08-05 16:09:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,336828445.0
